Alkem Sees 8-11% Growth For Indian Pharmaceutical Industry
Alkem Laboratories projects once the pandemic subsides, Indian pharma industry will recover to 8-11% growth rate with normalcy occurring in business operations.
Deloitte Latest Survey - Mature R&D Yields Enterprise Value
Clinical trial expenses and trial failure rates were more likely to be decreased in organisations with developed RWE skills through the usage of RWE in R&D.
Switzerland To Get A $518mn Fill-Finish Plant From Lonza
The project would symbolize the accomplishment of the goal of the company to deliver comprehensive CDMO services from inception to delivery in their entirety.
Pfizer And Touchlight Enter Into A Patent Licence Agreement
The collaboration between both the companies will take into consideration the production of mRNA-based vaccines, therapeutics, as well as the gene treatments.
AstraZeneca, GSK Overcame Q2 Issues While Roche Stocks Fell
AstraZeneca, GSK seem to have withstood the storms better than most, given the fact that their earnings reports for second quarter are due in the coming weeks.